STIM•benzinga•
Canaccord Genuity Maintains Buy on Neuronetics, Raises Price Target to $8
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 5, 2025 by benzinga